Diclofenac Sodium Topical Gel to Reduce Injection Site Discomfort in Patients Taking Glatiramer Acetate
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effect of Diclofenac Sodium Topical Gel (DSTG) on
injection site reaction following self-administer glatiramer acetate in people with Multiple
Sclerosis.